Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05018221 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Better Evidence and Translation for Calciphylaxis

Study acronym: BEAT-Calci
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 14 to 21
    • Collaborators: 3 to 5
    v10
  2. Study sites: 13 to 14v9
  3. Study sites: 12 to 13v8
  4. Primary and study completion dates: Dec 2026 to Dec 2029
    • Study sites: 11 to 12
    v7
  5. Study sites: 24 to 11v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 19 to 24v5
  2. Study sites: 16 to 19v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 16
    • Start date changed from estimate of Aug 2021 to Aug 26, 2021
    v3
  4. Secondary endpoints: details revised at 5 of 27 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This global platform study will evaluate multiple interventions, across several domains of therapeutic care, in adult patients with kidney failure and newly diagnosed calciphylaxis.
Trial Details
NCT Number NCT05018221
Lead Sponsor University of Sydney
Collaborators: Australasian Kidney Trials Network, Northern Care Alliance NHS Foundation Trust, Waitemata District Health Board, Vantive Health LLC, Berry Consultants
Conditions
(from sponsor)		 Calciphylaxis
Related terms Calciphylaxis
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov